One in three people are over the age of 65 in Japan, with medical costs continuing to balloon to over 40 trillion yen.

Over the years, M3 has invested in roughly 30 healthcare related venture companies tackling this social problem, in line with its corporate mission of “making use of the Internet to increase, as much as possible, the number of people who can live longer and healthier lives, and to reduce, as much as possible, the amount of unnecessary medical costs,” of which 9 have IPOed so far.

At this juncture, we have established the “1P1Y Fund” corporate venture fund in order to accelerate progress in 7P projects^*1 in actualizing the M3 mission.

Investments through this fund and utilization of resources across M3’s ecosystem will boost the development and new business creation across the ventures in the fund, ultimately to bring paradigm shifts within the medical community.

^*1 7P projects: New service expansion (AI based diagnostics, genetic testing, consolidation of stroke rehabilitation centers, etc.) that extend beyond pharmaceutical marketing, and their integration into comprehensive solutions for issues across the healthcare industry.